Tuoxin Pharmaceutical Group Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 652.41 million compared to CNY 241.28 million a year ago. Revenue was CNY 656.98 million compared to CNY 246.65 million a year ago.

Net income was CNY 309.53 million compared to CNY 54.06 million a year ago. Basic earnings per share from continuing operations was CNY 2.46 compared to CNY 0.43 a year ago. Diluted earnings per share from continuing operations was CNY 2.46 compared to CNY 0.43 a year ago.